Y030_UREPA
ID Y030_UREPA Reviewed; 747 AA.
AC Q9PRB5;
DT 01-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT 01-OCT-2000, sequence version 1.
DT 25-MAY-2022, entry version 89.
DE RecName: Full=Uncharacterized protein UU030;
GN OrderedLocusNames=UU030;
OS Ureaplasma parvum serovar 3 (strain ATCC 700970).
OC Bacteria; Tenericutes; Mollicutes; Mycoplasmataceae; Ureaplasma.
OX NCBI_TaxID=273119;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=ATCC 700970;
RX PubMed=11048724; DOI=10.1038/35037619;
RA Glass J.I., Lefkowitz E.J., Glass J.S., Heiner C.R., Chen E.Y.,
RA Cassell G.H.;
RT "The complete sequence of the mucosal pathogen Ureaplasma urealyticum.";
RL Nature 407:757-762(2000).
CC -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane
CC protein {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AF222894; AAF30435.1; -; Genomic_DNA.
DR RefSeq; WP_010891653.1; NC_002162.1.
DR AlphaFoldDB; Q9PRB5; -.
DR STRING; 273119.UU030; -.
DR EnsemblBacteria; AAF30435; AAF30435; UU030.
DR GeneID; 29672753; -.
DR KEGG; uur:UU030; -.
DR PATRIC; fig|273119.6.peg.30; -.
DR eggNOG; ENOG5033T8T; Bacteria.
DR HOGENOM; CLU_372116_0_0_14; -.
DR OMA; NSHHENW; -.
DR Proteomes; UP000000423; Chromosome.
DR GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR InterPro; IPR022382; Mycoplasma_peptidase_DUF31.
DR InterPro; IPR009003; Peptidase_S1_PA.
DR Pfam; PF01732; DUF31; 1.
DR SUPFAM; SSF50494; SSF50494; 1.
PE 4: Predicted;
KW Membrane; Reference proteome; Transmembrane; Transmembrane helix.
FT CHAIN 1..747
FT /note="Uncharacterized protein UU030"
FT /id="PRO_0000220782"
FT TRANSMEM 7..27
FT /note="Helical"
FT /evidence="ECO:0000255"
SQ SEQUENCE 747 AA; 85861 MW; 68FFD940C28D02AF CRC64;
MNLKTKFFLK VISVIAPIVI IPTILANCAH INSNELDNAK TNLKGSVEVV NINPYKTKQM
LASNINKEQI NSYFIFIFNL IKTNQKIEEK ILDKNDYEIL NWAANDNDGT LGINIYIKTT
KQSYLINTKP VFLTDKQNNY LQELKYKTPA VYSIDEILKF SNNPYNLIHN NPYYREQLLR
AKIYFNQNEA NVDDSKLYMN KIGYSEFGSD VQKRLENAFK IRYDEQNIYQ INSPQILAKE
TKTLTSYIDK KTNNNYSINI ELIKKLIQIN PFGKLPKNFA QLINLIKKEE YPKFLTITKN
ESVDNIVVKD IYYRIIDRYA KLEFILEIYN KKTKQTVYLS ANFNQKNSGL LKNEDYFQYI
FDRTISLDLL TTKDGKNVEL NSGTGWIVDR IIDDSLPKNK IKLLIATNNH VMGWSNLAIS
KDNRMKSRWF NKQEYINYLE NNAGFISSNI YEDKDRYQYL LWGTAPLKSP VSNKYNSLSG
ISFSNLAKVY NITNQNFINR AWYIPQLSAN GIKINENLRT WYQINQEDIK SIKNGTLDFV
LVPMVFDIED IKEKLPNYYK VLNTKDEANW YIGLGNSKKY LPQLQLFSGG YPGDVNPNSS
AIVSWRGSKS YGSLIQAFDR EIKNESILDY YGPKQINNID GYQKVGEGYL NKLFNVGTRV
ITSDEIGDLG SGSSGSMIID SNFNLVGIHF ASLNSRAYGA PNDSMIGNLF VAQSQDLSGD
IDVRAAVIKK LKAENIYTYK LNPKVSS